ARUP's Laboratory Test Directory

Juvenile Polyposis Syndrome (BMPR1A) Deletion/Duplication : 2004984
[ image for: Patient History for Juvenile Polyposis (JPS)/Hereditary Hemorrhagic Telangiectasia (HHT)]
Patient History for Juvenile Polyposis (JPS)/Hereditary Hemorrhagic Telangiectasia (HHT)
  


Mnemonic: BMPR1A DD

Methodology: Polymerase Chain Reaction/Multiplex Ligation-dependent Probe Amplification
Performed: Varies
Reported: 14 days
Specimen Required: Collect: Lavender (EDTA), pink (K2EDTA) or yellow (ACD Solution A or B).

Specimen Preparation: Transport 3 mL whole blood. (Min: 1 mL)

Storage/Transport Temperature: Refrigerated.

Stability (collection to initiation of testing): Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable

Interpretive Data: Background Information for Juvenile Polyposis Syndrome (BMPR1A) Deletion/Duplication:
Characteristics:
Multiple juvenile (hamartomatous) polyps in the stomach, small intestine, colon, and rectum. Risk for colon cancer is 20 percent by age 35 and 70 percent by age 60.
Incidence:
1 in 16,000 to 100,000 individuals.
Inheritance:
Autosomal dominant.
Penetrance
: Greater than 90 percent for polyp development.
Cause:
Pathogenic BMPR1A and SMAD4 mutations.
Clinical Sensitivity:
99 percent.
Methodology:
Multiplex ligation-dependent probe amplification (MLPA) to detect large BMPR1A coding region deletions and duplications; BMPR1A exons 6 and 7 are not analyzed.
Analytical Sensitivity & Specificity:
99 percent.
Limitations:
Rare diagnostic errors can occur due to probe site mutations. Single base pair substitutions, small deletions/duplications, regulatory region mutations, and deep intronic mutations will not be detected. Large deletions/duplications of exons 6 and 7 will not be detected. The breakpoints of large deletions/duplications will not be determined. Mutations in genes other than BMPR1A are not evaluated.



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

Refer to Statement C under Testing Information at http://www.aruplab.com.
CPT Code(s): 83891 Isolation; 83896 x13 Nucleic acid probes; 83898 x13 Amplification; 83914 x13 Extension; 83909 Capillary electrophoresis; 83912 Interpretation and report - Additional CPT code modifiers may be required for procedures performed to test for oncologic or inherited disorders.
Cross References: BMPR1A (Juvenile Polyposis Syndrome (BMPR1A) Deletion/Duplication)
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org